M&A Deal Summary |
|
|---|---|
| Date | 2022-02-03 |
| Target | Aurex Laboratories |
| Sector | Life Science |
| Buyer(s) | APNAR Pharma |
| Deal Type | Add-on Acquisition |
SEARCH BY
APNAR Pharma is a privately owned, rapidly growing pharmaceutical company. APNAR Pharma develops, manufacture, package, sell, market, and distribute generic pharmaceuticals and OTCs. APNAR has R&D and manufacturing facilities in East Windsor, NJ, the United States, and Gavasad, Gujarat, India. APNAR Pharma is based in Chino, California.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: New Jersey M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2022 M&A | 1 of 1 |
